Clear Dermatology & Aesthetics Center

Scottsdale, Arizona 85255-4134

0 studies enrolling now · 7 studies all time

What they study most

Acne Vulgaris, Atopic Dermatitis, Glabellar Lines, Inflammatory Acne Vulgaris, Lateral Canthal Lines, Moderate to Severe Midface Volume Deficit, Skin Lesion

Studies at this site

• Saypha® VOLUME Lidocaine for Midface Augmentation — Completed
• MT10109L in the Long-term, Open-label Treatment of Glabellar Lines (GL) and Lateral Canthal Lines (LCL) — Completed
• Dermal Cooling System for Cryotherapy of Common Skin Conditions — Completed
• MT10109L in the Treatment of Lateral Canthal Lines With or Without Concurrent Treatment of Glabellar Lines — Completed
• A Study of Lebrikizumab (LY3650150) in Participants With Moderate-to-Severe Atopic Dermatitis — Completed
• Non-Significant Risk Study of Sebacia Microparticles in the Treatment of Facial Acne Vulgaris — Completed
• Pivotal Study of Sebacia Microparticles in the Treatment of Acne Vulgaris — Completed